ISRCTN43372293已完成1 期
A Phase I, randomized, double-blind, placebo-controlled, dose-escalating clinical trial with KH176
Khondrion0 个研究点目标入组 30 人开始时间: 2017年6月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/29037240
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Healthy as assessed by medical history, physical examination, vital signs, clinical laboratory, ECG
- •2. Adult males
排除标准
- •1. Allergies
- •2. Concomitant medication
- •3. Concomitant disease
- •4. Relevant surgery
- •5. Recent blood donation
研究者
相似试验
已完成
2 期
Cisplatin Ototoxicity attenuated by ASpirin Trial (COAST)CancerISRCTN83689269Southampton University Hospitals NHS Trust (UK)88
已完成
不适用
Studying the impact of Lorazepam on approach/avoidance behaviour in healthy individualsISRCTN12590498Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)60
已完成
2 期
Study to evaluate the safety and efficacy of CCX168 in subjects with renal vasculitis on background cyclophosphamide treatmentRenal VasculitisCirculatory SystemRenal vasculitisISRCTN53663626ChemoCentryx, Inc. (USA)60
已完成
不适用
A trial of Exenatide for the treatment of moderate severity Parkinson's diseaseTopic: Dementias and Neurodegenerative Diseases Research NetworkSubtopic: Parkinson?s DiseaseDisease: Parkinson's diseaseNervous System DiseasesParkinson diseaseISRCTN75891427niversity College London (UK)60
已完成
2 期
Innovations in the management of musculoskeletal pain with alpha-lipoic acidFibromyalgiaISRCTN58259979Physicians Services Incorporated Foundation27